Welcome to our dedicated page for TRAFALGAR INTERNATIONAL SEC filings (Ticker: GCAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRAFALGAR INTERNATIONAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRAFALGAR INTERNATIONAL's regulatory disclosures and financial reporting.
Trafalgar International, Inc. (GCAN) reported no revenue for the three and six months ended June 30, 2026, continuing its pre‑revenue status. Operating expenses fell sharply, leading to an operating loss of $11,555 for the quarter and $44,931 for the first half of 2026.
Net income was driven entirely by non‑operating items. The company recorded a $621,450 gain on cancellation of debt and a $1,483 gain on cancellation of preferred stock A, producing quarterly net income of $611,378 and first‑half net income of $578,002, compared with losses in 2025. Cash was only $111 at June 30, 2026, with current liabilities of $12,239 and negative working capital of $12,128, and management concluded there is substantial doubt about its ability to continue as a going concern through June 2027.
During the period, all related‑party loans and third‑party notes payable were eliminated, materially reducing liabilities and stockholders’ deficiency to $(12,128). A 1‑for‑1,500 reverse stock split became effective in October 2025, and 994,379 common shares were outstanding as of August 14, 2026. On June 29, 2026, control shifted to Trafalgar Asset Management, LLC, which now holds approximately 96.62% of voting power via Series A and super‑voting Series B preferred stock, and the company is transitioning from cannabis‑focused activities toward broader financial services, technology and intellectual property businesses.
The Greater Cannabis Company, Inc. describes a recent change in control and resulting changes to its Board and management. On June 29, 2026, Trafalgar Asset Management, LLC, owned and controlled by Porfirio Sanchez Talavera, acquired a controlling interest by purchasing 7,628,665 shares of Series A Preferred Stock and 1,000 shares of Series B Preferred Stock, giving the controlling shareholder the voting power to determine Board elections and other stockholder matters.
Following this transaction, Sanchez Talavera became Chief Executive Officer, Chairman and sole director. On July 29, 2026, he approved the appointments of Carlos Septién, Michelle Cervantes Vivanco, and Ernesto Gómez Berjón to the Board, which will take effect after the ten-day Rule 14f-1 notice period, resulting in a four-member Board that also fills the key executive roles of COO, CFO and Chief Growth Officer.
The company’s capital structure consists of 2,000,000,000 authorized common shares with 994,379 outstanding, 10,000,000 authorized Series A Preferred with 7,628,665 outstanding, and 1,000 outstanding Series B Preferred. Series A carries 1.76 votes per share, while the Series B collectively carries 51% of total voting power, leading to an aggregate voting power of 96.62% held by the controlling shareholder and related entities. The statement also notes compromise and extinguishment of certain indebtedness in connection with the share purchase and provides recent executive compensation and governance disclosures.
The Greater Cannabis Company, Inc. approved significant governance and capital-structure changes on July 29, 2026. The board expanded to add Carlos Septién, Michelle Cervantes Vivanco and Ernesto Gómez Berjón as directors, with Septién becoming Chief Operating Officer, Cervantes Vivanco Chief Financial Officer and Gómez Berjón Chief Growth Officer, while Porfirio Sanchez Talavera remains Chief Executive Officer and Chairman. These director appointments become effective after a ten-day Schedule 14F-1 information period.
The board authorized a corporate name change to Trafalgar International, Inc. and a one-for-five (1-for-5) reverse stock split of issued and outstanding Common Stock, with fractional shares rounded up, leaving authorized Common and Preferred Stock unchanged. Articles of Amendment and related regulatory submissions, including FINRA corporate action notifications, will determine the effective dates. The board also adopted Amended and Restated Bylaws to align with the company’s current governance structure.
Trafalgar Asset Management, LLC, wholly owned by Porfirio Sanchez Talavera, acquired 7,628,665 shares of Series A Preferred Stock and 1,000 shares of Series B Preferred Stock of Greater Cannabis Company, Inc., totaling 7,629,665 preferred shares. These securities carry 28,435,885 votes, representing 96.62% of the issuer’s aggregate voting power and 100% of the Series A and Series B preferred class.
The preferred shares were purchased in privately negotiated transactions under Series A and Series B Share Purchase Agreements dated June 29, 2026. As part of the change in control, Porfirio Sanchez Talavera became Chief Executive Officer, Chairman of the Board and a director, while the former CEO resigned all officer roles and will resign as director after a 10-day Rule 14f-1 period.
Trafalgar Asset Management, LLC, identified as a ten percent owner of Greater Cannabis Company, Inc., reports beneficial holdings of 7,628,665 shares of Series A Preferred Stock and 1,000 shares of Series B Preferred Stock as of June 29, 2026. The report notes that Porfirio Sanchez Talavera, as the beneficial owner of Trafalgar, may be deemed to share voting and investment power over these securities.
Greater Cannabis Company, Inc. director, CEO, Chairman and more-than-10% owner Porfirio Sanchez Talavera reported his initial beneficial holdings. He indirectly holds 1,000 shares of Series B Preferred Stock and 7,628,665 shares of Series A Preferred Stock through Trafalgar Asset Management, LLC as of June 29, 2026.
The Greater Cannabis Company, Inc. furnished a Schedule 14F-1 Information Statement reporting a change in control following a Share Purchase by Trafalgar Asset Management, LLC that gave it voting control of the company.
The filing states 7,628,665 shares of Series A Preferred and 1,000 shares of Series B Preferred were purchased, yielding approximately 96.62% of aggregate voting power as of June 29, 2026. Porfirio Sanchez Talavera was appointed Chairman and Chief Executive Officer and will remain as sole director after the 10-day Rule 14f-1 period expires.
The Greater Cannabis Company reported a change in control and leadership following privately negotiated transactions completed on June 29, 2026. Trafalgar Asset Management, LLC, owned and controlled by Porfirio Sánchez Talavera, purchased 7,628,665 shares of Series A Preferred Stock and 1,000 shares of Series B Preferred Stock, representing all outstanding shares of both classes. Based on 994,379 common shares outstanding, the preferred holdings give Trafalgar approximately 96.62% of the company’s total voting power, establishing clear voting control.
Concurrently, the company entered into Debt Cancellation and Release Agreements with certain creditors, under which specified indebtedness was compromised, settled, canceled, and extinguished. In connection with the change in control, Sánchez Talavera was appointed Chief Executive Officer, Chairman, and sole director (after a Rule 14f‑1 transition period), while long‑time executive Aitan Zacharin resigned from all officer roles and will depart the board following the required notice period.
The Greater Cannabis Company, Inc. reports unaudited results for the quarter ended March 31, 2026, with no revenue and a net loss of $33,376. Operating expenses fell to $33,376 from $43,536 a year earlier, mainly from lower stock-based and other operating costs.
Cash was only $1,439 against current liabilities of $776,464, resulting in a stockholders’ deficit of $775,025. Management explicitly concludes there is substantial doubt about the company’s ability to continue as a going concern through March 2027 without new funding.
The company continues to pursue development of a cannabinoid therapeutic licensed from Shaare Zedek Scientific Ltd., with Phase II clinical work dependent on securing specialized API and additional capital. A 1-for-1,500 reverse stock split and creation of super-voting Series B preferred shares have centralized voting control while leaving 944,935 common shares outstanding as of May 6, 2026.
The Greater Cannabis Company, Inc. reported a full-year 2025 net loss of $331,612 on $0 in revenue, similar to 2024. Operating expenses rose to $183,005 from $156,276, reflecting ongoing development activity without commercial sales.
Cash declined to $815 at December 31, 2025, against current liabilities of $742,464, and the auditor highlighted substantial doubt about the company’s ability to continue as a going concern. Management is focused on a licensed cannabinoid therapy from Shaare Zedek Scientific and plans a Phase II clinical trial once specialized API is sourced and additional funding is raised. During 2025 the company completed a 1-for-1,500 reverse stock split and created Series B Preferred Shares, giving its CEO majority voting control while common shares outstanding reached 944,935 as of March 16, 2026.